ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.
Vladimir A Martínez-RojasAura M Jiménez-GarduñoDaniela MichelattiLaura TosattoMarta MarchiorettoDaniele ArosioManuela BassoMaria PennutoCarlo MusioPublished in: Journal of molecular neuroscience : MN (2020)
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by expansions of a polyglutamine (polyQ) tract in the androgen receptor (AR) gene. SBMA is associated with the progressive loss of lower motor neurons, together with muscle weakness and atrophy. PolyQ-AR is converted to a toxic species upon binding to its natural ligands, testosterone, and dihydrotestosterone (DHT). Our previous patch-clamp studies on a motor neuron-derived cell model of SBMA showed alterations in voltage-gated ion currents. Here, we identified and characterized chloride currents most likely belonging to the chloride channel-2 (ClC-2) subfamily, which showed significantly increased amplitudes in the SBMA cells. The treatment with the pituitary adenylyl cyclase-activating polypeptide (PACAP), a neuropeptide with a proven protective effect in a mouse model of SBMA, recovered chloride channel current alterations in SBMA cells. These observations suggest that the CIC-2 currents are affected in SBMA, an alteration that may contribute and potentially determine the pathophysiology of the disease.
Keyphrases
- induced apoptosis
- spinal cord
- mouse model
- cell cycle arrest
- single cell
- signaling pathway
- cell therapy
- multiple sclerosis
- stem cells
- resistance training
- oxidative stress
- cell death
- healthcare
- mesenchymal stem cells
- genome wide
- dna methylation
- transcription factor
- cell proliferation
- gene expression
- body composition
- high intensity
- copy number
- health insurance
- affordable care act
- growth hormone